Finally, the finding that NGF/TrkA signaling also controls proliferation and invasiveness of AR-positive C4-2B cells strongly suggests that targeting of this axis might be of value in the clinical approach of ADT-refractory PC. The gene discussed is AR; the disease is pachyonychia congenita.